191 related articles for article (PubMed ID: 33256656)
1. A prospective follow-up study of the relationship between high-sensitivity C-reactive protein and primary liver cancer.
Siyin ST; Liu T; Li W; Yao N; Xu G; Qu J; Chen Y
BMC Cancer; 2020 Nov; 20(1):1168. PubMed ID: 33256656
[TBL] [Abstract][Full Text] [Related]
2. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
Song M; Liu T; Liu H; Zhang Q; Zhang Q; Wang Y; Ma X; Cao L; Shi H
BMC Cancer; 2022 Aug; 22(1):853. PubMed ID: 35927639
[TBL] [Abstract][Full Text] [Related]
3. Relationship between high-sensitivity C reactive protein and the risk of gallstone disease: results from the Kailuan cohort study.
Liu T; Siyin ST; Yao N; Duan N; Xu G; Li W; Qu J; Liu S
BMJ Open; 2020 Sep; 10(9):e035880. PubMed ID: 32963062
[TBL] [Abstract][Full Text] [Related]
4. Elevated fasting serum glucose levels increase the risk of hepatocellular carcinoma: A prospective cohort study.
Liu T; Wang W; Cui H; Sun M; Wang Y; Liu X; Cao L; Liu H; Liu S
Medicine (Baltimore); 2019 Jul; 98(30):e16369. PubMed ID: 31348238
[TBL] [Abstract][Full Text] [Related]
5. Risk of primary liver cancer associated with gallstones and cholecystectomy: A competing risks analysis.
Liu T; Siyin ST; Yao N; Xu G; Chen YT; Duan N; Li W; Qu J; Liu S
Medicine (Baltimore); 2020 Sep; 99(39):e22428. PubMed ID: 32991479
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome, high-sensitivity C-reactive protein levels and the risk of new-onset atrial fibrillation: Results from the Kailuan Study.
Wang Z; Wang B; Li X; Zhang S; Wu S; Xia Y
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):102-109. PubMed ID: 33500102
[TBL] [Abstract][Full Text] [Related]
7. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.
Su J; Cui L; Yang W; Shi H; Jin C; Shu R; Li H; Zeng X; Wu S; Gao X
PLoS One; 2019; 14(2):e0211946. PubMed ID: 30768617
[TBL] [Abstract][Full Text] [Related]
8. Interactive effect of increased high sensitive C-reactive protein and dyslipidemia on cardiovascular diseases: a 12-year prospective cohort study.
Bafei SEC; Zhao X; Chen C; Sun J; Zhuang Q; Lu X; Chen Y; Gu X; Liu F; Mu J; Wei L; Wei P; Yin Y; Xie H; Yang S; Shen C
Lipids Health Dis; 2023 Jul; 22(1):95. PubMed ID: 37403063
[TBL] [Abstract][Full Text] [Related]
9. Sex and age differences in the association between high sensitivity C-reactive protein and all-cause mortality: A 12-year prospective cohort study.
Bafei SEC; Yang S; Chen C; Gu X; Mu J; Liu F; Sun J; Zhuang Q; Wei P; Zhao X; Chen Y; Yin Y; Xie H; Shen C
Mech Ageing Dev; 2023 Apr; 211():111804. PubMed ID: 36967048
[TBL] [Abstract][Full Text] [Related]
10. High-Sensitivity C-Reactive Protein and Ischemic Stroke in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study.
Jia M; Shi Y; Wang Y; Wang M; Zhang L; He Q; Yuan T
J Healthc Eng; 2022; 2022():9711712. PubMed ID: 35399841
[TBL] [Abstract][Full Text] [Related]
11. The Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Chronic Kidney Diseases.
Gao J; Wang A; Li X; Li J; Zhao H; Zhang J; Liang J; Chen S; Wu S
Kidney Blood Press Res; 2020; 45(1):84-94. PubMed ID: 31794962
[TBL] [Abstract][Full Text] [Related]
12. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
13. [The prospective study of association between C-reactive protein and hypertension in community population].
Lu HH; Guo ZR; Hu XS; Wu M; Zhou MH; Zhou ZY
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1026-30. PubMed ID: 24507232
[TBL] [Abstract][Full Text] [Related]
14. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up.
Wang C; Yatsuya H; Tamakoshi K; Uemura M; Li Y; Wada K; Yamashita K; Kawaguchi L; Toyoshima H; Aoyama A
Diabetes Metab Res Rev; 2013 Jul; 29(5):398-405. PubMed ID: 23463453
[TBL] [Abstract][Full Text] [Related]
15. [Association between high-sensitivity C-reactive protein and both cardiovascular, total mortality events in middle-aged Chinese adults].
Dong Y; Wang ZW; Wang X; Tian Y; Zhang LF; Chen Z; Cao HQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):428-432. PubMed ID: 29699031
[No Abstract] [Full Text] [Related]
16. Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.
Peña JM; Aspberg S; MacFadyen J; Glynn RJ; Solomon DH; Ridker PM
JAMA Intern Med; 2015 Feb; 175(2):171-7. PubMed ID: 25437881
[TBL] [Abstract][Full Text] [Related]
17. Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality.
Lee DY; Rhee EJ; Chang Y; Sohn CI; Shin HC; Ryu S; Lee WY
Metabolism; 2018 Apr; 81():52-62. PubMed ID: 29191456
[TBL] [Abstract][Full Text] [Related]
18. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
Wang AY; Woo J; Lam CW; Wang M; Sea MM; Lui SF; Li PK; Sanderson J
J Am Soc Nephrol; 2003 Jul; 14(7):1871-9. PubMed ID: 12819248
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort.
Geluk CA; Post WJ; Hillege HL; Tio RA; Tijssen JGP; van Dijk RB; Arnold Dijk W; Bakker SJL; de Jong PE; van Gilst WH; Zijlstra F
Atherosclerosis; 2008 Jan; 196(1):372-382. PubMed ID: 17157301
[TBL] [Abstract][Full Text] [Related]
20. Targeting high-sensitivity C-reactive protein levels in acute coronary syndrome patients undergoing contemporary lipid-lowering therapy: a sub-analysis of the HIJ-PROPER trial.
Kawada-Watanabe E; Yamaguchi J; Sekiguchi H; Arashi H; Ogawa H; Hagiwara N
J Cardiol; 2020 May; 75(5):500-506. PubMed ID: 31699568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
